[1]
|
Wardlaw, J.M., Smith, C. and Dichgans, M. (2013) Mechanisms of Sporadic Cerebral Small Vessel Disease: Insights from Neuroimaging. The Lancet Neurology, 12, 483-497. https://doi.org/10.1016/S1474-4422(13)70060-7
|
[2]
|
Li, Q., et al. (2018) Cerebral Small Vessel Disease. Cell Transplantation, 27, 1711-1722.
https://doi.org/10.1177/0963689718795148
|
[3]
|
Wardlaw, J.M., et al. (2013) Neuroimaging Standards for Re-search into Small Vessel Disease and Its Contribution to Ageing and Neurodegeneration. The Lancet Neurology, 12, 822-838. https://doi.org/10.1016/S1474-4422(13)70124-8
|
[4]
|
Cannistraro, R.J., et al. (2019) CNS Small Vessel Disease: A Clinical Review. Neurology, 92, 1146-1156.
https://doi.org/10.1212/WNL.0000000000007654
|
[5]
|
Pantoni, L. (2010) Cerebral Small Vessel Disease: from Pathogenesis and Clinical Characteristics to Therapeutic Challenges. The Lancet Neurology, 9, 689-701. https://doi.org/10.1016/S1474-4422(10)70104-6
|
[6]
|
Wang, Z., et al. (2021) Risk Factors of Cerebral Small Ves-sel Disease: A Systematic Review and Meta-Analysis. Medicine (Baltimore), 100, e28229. https://doi.org/10.1097/MD.0000000000028229
|
[7]
|
Kim, H., et al. (2013) Obstructive Sleep Apnea as a Risk Factor for Cerebral White Matter Change in a Middle-Aged and Older General Population. Sleep, 36, 709-715. https://doi.org/10.5665/sleep.2632
|
[8]
|
Backhouse, E.V., et al. (2017) Early Life Risk Factors for Cerebrovascular Disease: A Systematic Review and Meta-Analysis. Neurology, 88, 976-984. https://doi.org/10.1212/WNL.0000000000003687
|
[9]
|
De Leeuw, F.E., et al. (2001) Prevalence of Cerebral White Matter Lesions in Elderly People: A Population Based Magnetic Resonance Imaging Study. The Rotterdam Scan Study. Journal of Neurology, Neurosurgery and Psychiatry, 70, 9-14. https://doi.org/10.1136/jnnp.70.1.9
|
[10]
|
Hilal, S., et al. (2017) Prevalence, Risk Factors and Consequences of Cerebral Small Vessel Diseases: Data from Three Asian Coun-tries. Journal of Neurology, Neurosurgery and Psychiatry, 88, 669-674.
https://doi.org/10.1136/jnnp-2016-315324
|
[11]
|
Poels, M.M., et al. (2010) Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study. Stroke, 41, S103-S106. https://doi.org/10.1161/STROKEAHA.110.595181
|
[12]
|
Obermeier, B., Daneman, R. and Ransohoff, R.M. (2013) Development, Maintenance and Disruption of the Blood-Brain Barrier. Nature Medicine, 19, 1584-1596. https://doi.org/10.1038/nm.3407
|
[13]
|
Keaney, J. and Campbell, M. (2015) The Dynamic Blood-Brain Barrier. The FEBS Journal, 282, 4067-4079.
https://doi.org/10.1111/febs.13412
|
[14]
|
Kleinberger, G., et al. (2017) The FTD-Like Syndrome Causing TREM2 T66M Mutation Impairs Microglia Function, Brain Perfusion, and Glucose Metabolism. The EMBO Journal, 36, 1837-1853.
https://doi.org/10.15252/embj.201796516
|
[15]
|
Liebner, S., et al. (2018) Functional Morphology of the Blood-Brain Barrier in Health and Disease. Acta Neuropathologica, 135, 311-336. https://doi.org/10.1007/s00401-018-1815-1
|
[16]
|
Dudvarski Stankovic, N., et al. (2016) Microglia-Blood Vessel Interactions: A Double-Edged Sword in Brain Pathologies. Acta Neuropathologica, 131, 347-363. https://doi.org/10.1007/s00401-015-1524-y
|
[17]
|
Varatharaj, A. and Galea, I. (2017) The Blood-Brain Barrier in Systemic Inflammation. Brain, Behavior, and Immunity, 60, 1-12. https://doi.org/10.1016/j.bbi.2016.03.010
|
[18]
|
Haruwaka, K., et al. (2019) Dual Microglia Effects on Blood Brain Barrier Permeability Induced by Systemic Inflammation. Nature Communications, 10, Article No. 5816. https://doi.org/10.1038/s41467-019-13812-z
|
[19]
|
Jalal, F.Y., et al. (2015) Hypoxia-Induced Neuroinflammatory White-Matter Injury Reduced by Minocycline in SHR/SP. Journal of Cerebral Blood Flow & Metabolism, 35, 1145-1153. https://doi.org/10.1038/jcbfm.2015.21
|
[20]
|
Ueno, M., et al. (2002) Blood-Brain Barrier Disruption in White Matter Lesions in a Rat Model of Chronic Cerebral Hypoperfusion. Journal of Cerebral Blood Flow & Metabo-lism, 22, 97-104.
https://doi.org/10.1097/00004647-200201000-00012
|
[21]
|
Tomimoto, H., et al. (1996) Alterations of the Blood-Brain Barrier and Glial Cells in White-Matter Lesions in Cerebrovascular and Alzheimer’s Disease Patients. Stroke, 27, 2069-2074. https://doi.org/10.1161/01.STR.27.11.2069
|
[22]
|
Forsberg, K.M.E., et al. (2018) Endothelial Dam-age, Vascular Bagging and Remodeling of the Microvascular Bed in Human Microangiopathy with Deep White Matter Lesions. Acta Neuropathologica Communications, 6, Article No. 128.
https://doi.org/10.1186/s40478-018-0632-z
|
[23]
|
Young, V.G., Halliday, G.M. and Kril, J.J. (2008) Neuropatho-logic Correlates of White Matter Hyperintensities. Neurology, 71, 804-811. https://doi.org/10.1212/01.wnl.0000319691.50117.54
|
[24]
|
Wardlaw, J.M., et al. (2009) Lacunar Stroke Is Associ-ated with Diffuse Blood-Brain Barrier Dysfunction. Annals of Neurology, 65, 194-202. https://doi.org/10.1002/ana.21549
|
[25]
|
Topakian, R., et al. (2010) Blood-Brain Barrier Permeability Is Increased in Normal-Appearing White Matter in Patients with Lacunar Stroke and Leucoaraiosis. Journal of Neurology, Neurosurgery and Psychiatry, 81, 192-197.
https://doi.org/10.1136/jnnp.2009.172072
|
[26]
|
Held, C., et al. (2017) Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. Journal of the American Heart Association, 6, e005077.
https://doi.org/10.1161/JAHA.116.005077
|
[27]
|
Nakahira, K., et al. (2011) Autophagy Proteins Regulate Innate Immune Responses by Inhibiting the Release of Mitochondrial DNA Mediated by the NALP3 Inflammasome. Nature Immunology, 12, 222-230.
https://doi.org/10.1038/ni.1980
|
[28]
|
Oka, T., et al. (2012) Mitochondrial DNA That Escapes from Autophagy Causes Inflammation and Heart Failure. Nature, 485, 251-255. https://doi.org/10.1038/nature10992
|
[29]
|
Martinvalet, D. (2018) The Role of the Mitochondria and the Endoplasmic Reticulum Contact Sites in the Development of the Immune Responses. Cell Death & Disease, 9, Article No. 336.
https://doi.org/10.1038/s41419-017-0237-7
|
[30]
|
Farkas, E., et al. (2004) Experimental Cerebral Hypoperfusion Induces White Matter Injury and Microglial Activation in the Rat Brain. Acta Neuropathologica, 108, 57-64. https://doi.org/10.1007/s00401-004-0864-9
|
[31]
|
Jalal, F.Y., et al. (2012) Myelin Loss Associated with Neuroin-flammation in Hypertensive Rats. Stroke, 43, 1115-1122.
https://doi.org/10.1161/STROKEAHA.111.643080
|
[32]
|
Kaiser, D., et al. (2014) Spontaneous White Matter Dam-age, Cognitive Decline and Neuroinflammation in Middle-Aged Hypertensive Rats: An Animal Model of Early-Stage Cerebral Small Vessel Disease. Acta Neuropathologica Communications, 2, Article No. 169. https://doi.org/10.1186/s40478-014-0169-8
|
[33]
|
Wan, S., et al. (2023) Plasma Inflammatory Biomarkers in Cere-bral Small Vessel Disease: A Review. CNS Neuroscience & Therapeutics, 29, 498-515. https://doi.org/10.1111/cns.14047
|
[34]
|
Ling, C., et al. (2021) The Effect of Race and Shear Stress on CRP-Induced Responses in Endothelial Cells. Mediators of Inflammation, 2021, Article ID: 6687250. https://doi.org/10.1155/2021/6687250
|
[35]
|
Pasceri, V., Willerson, J.T. and Yeh, E.T. (2000) Direct Proinflamma-tory Effect of C-Reactive Protein on Human Endothelial Cells. Circulation, 102, 2165-2168. https://doi.org/10.1161/01.CIR.102.18.2165
|
[36]
|
Nishida, E., et al. (2016) Serum Amyloid A Promotes E-Selectin Expression via Toll-Like Receptor 2 in Human Aortic Endothelial Cells. Mediators of Inflammation, 2016, Article ID: 7150509. https://doi.org/10.1155/2016/7150509
|
[37]
|
Eber, B. and Schumacher, M. (1993) Fibrinogen: Its Role in the Hemostatic Regulation in Atherosclerosis. Seminars in Thrombosis and Hemostasis, 19, 104-107. https://doi.org/10.1055/s-2007-994012
|
[38]
|
Lominadze, D., et al. (2010) Mechanisms of Fibrinogen-Induced Mi-crovascular Dysfunction during Cardiovascular Disease. Acta Physiologica (Oxf), 198, 1-13. https://doi.org/10.1111/j.1748-1716.2009.02037.x
|
[39]
|
Lominadze, D., et al. (2005) Fibrinogen and Fragment D-Induced Vascular Constriction. American Journal of Physiology-Heart and Circulatory Physiology, 288, H1257-H1264. https://doi.org/10.1152/ajpheart.00856.2004
|
[40]
|
Muradashvili, N., et al. (2011) Fibrinogen Alters Mouse Brain Endothelial Cell Layer Integrity Affecting Vascular Endothelial Cadherin. Biochemical and Biophysical Re-search Communications, 413, 509-514.
https://doi.org/10.1016/j.bbrc.2011.07.133
|
[41]
|
Patibandla, P.K., et al. (2009) Fibrinogen Induces Alterations of Endothelial Cell Tight Junction Proteins. Journal of Cellular Physiology, 221, 195-203. https://doi.org/10.1002/jcp.21845
|
[42]
|
Tarkowski, E., et al. (2003) Correlation between Intrathecal Sulfatide and TNF-Alpha Levels in Patients with Vascular Dementia. Dementia and Geriatric Cognitive Disorders, 15, 207-211. https://doi.org/10.1159/000068780
|
[43]
|
Guldiken, B., et al. (2007) Serum Osteoprotegerin Levels in Patients with Acute Atherothrombotic Stroke and Lacunar Infarct. Thrombosis Research, 120, 511-516. https://doi.org/10.1016/j.thromres.2006.12.004
|
[44]
|
Schoch, H.J., Fischer, S. and Marti, H.H. (2002) Hypox-ia-Induced Vascular Endothelial Growth Factor Expression Causes Vascular Leakage in the Brain. Brain, 125, 2549-2557. https://doi.org/10.1093/brain/awf257
|
[45]
|
Zhang, J.B., et al. (2016) Association of Serum Vascular Endothelial Growth Factor Levels and Cerebral Microbleeds in Patients with Alzheimer’s Disease. European Journal of Neurology, 23, 1337-1342.
https://doi.org/10.1111/ene.13030
|
[46]
|
Perkins, L.A., Anderson, C.J. and Novelli, E.M. (2019) Targeting P-Selectin Adhesion Molecule in Molecular Imaging: P-Selectin Expression as a Valuable Imaging Biomarker of In-flammation in Cardiovascular Disease. Journal of Nuclear Medicine, 60, 1691-1697. https://doi.org/10.2967/jnumed.118.225169
|
[47]
|
De Leeuw, F.E., et al. (2002) Endothelial Cell Activation Is Asso-ciated with Cerebral White Matter Lesions in Patients with Cerebrovascular Disease. Annals of the New York Academy of Sciences, 977, 306-314.
https://doi.org/10.1111/j.1749-6632.2002.tb04831.x
|
[48]
|
Fassbender, K., et al. (1999) Adhesion Molecules in Cerebrovascular Diseases. Evidence for an Inflammatory Endothelial Activation in Cerebral Large- and Small-Vessel Disease. Stroke, 30, 1647-1650.
https://doi.org/10.1161/01.STR.30.8.1647
|
[49]
|
Kario, K., et al. (2001) Hyperinsulinemia and Hemostatic Abnor-malities Are Associated with Silent Lacunar Cerebral Infarcts in Elderly Hypertensive Subjects. Journal of the American College of Cardiology, 37, 871-877.
https://doi.org/10.1016/S0735-1097(00)01172-4
|
[50]
|
Low, A., et al. (2019) Inflammation and Cerebral Small Vessel Disease: A Systematic Review. Ageing Research Reviews, 53, Article 100916. https://doi.org/10.1016/j.arr.2019.100916
|
[51]
|
Wada, M., et al. (2011) Plasma Fibrinogen, Global Cognitive Func-tion, and Cerebral Small Vessel Disease: Results of a Cross-Sectional Study in Community-Dwelling Japanese Elderly. Internal Medicine, 50, 999-1007.
https://doi.org/10.2169/internalmedicine.50.4752
|
[52]
|
Fornage, M., et al. (2008) Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study. Stroke, 39, 1952-1959. https://doi.org/10.1161/STROKEAHA.107.508135
|
[53]
|
Mitaki, S., et al. (2016) C-Reactive Protein Levels Are Associated with Cerebral Small Vessel-Related Lesions. Acta Neurologica Scandinavica, 133, 68-74. https://doi.org/10.1111/ane.12440
|
[54]
|
Hilal, S., et al. (2018) C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction with Magnetic Resonance Imaging Markers. Stroke, 49, 2692-2698. https://doi.org/10.1161/STROKEAHA.118.022317
|
[55]
|
Koh, S.H., et al. (2011) Microbleeds and Free Active MMP-9 Are Independent Risk Factors for Neurological Deterioration in Acute Lacunar Stroke. European Journal of Neurology, 18, 158-164.
https://doi.org/10.1111/j.1468-1331.2010.03100.x
|
[56]
|
Noz, M.P., et al. (2018) Trained Immunity Characteristics Are Associated with Progressive Cerebral Small Vessel Disease. Stroke, 49, 2910-2917. https://doi.org/10.1161/STROKEAHA.118.023192
|
[57]
|
Vermeer, S.E., et al. (2002) Homocysteine, Silent Brain Infarcts, and White Matter Lesions: The Rotterdam Scan Study. Annals of Neurology, 51, 285-289. https://doi.org/10.1002/ana.10111
|
[58]
|
Pavlovic, A.M., et al. (2011) Increased Total Homocysteine Level Is Asso-ciated with Clinical Status and Severity of White Matter Changes in Symptomatic Patients with Subcortical Small Vessel Disease. Clinical Neurology and Neurosurgery, 113, 711-715. https://doi.org/10.1016/j.clineuro.2011.07.004
|
[59]
|
Gao, Y., et al. (2015) Homocysteine Level Is Associated with White Matter Hyperintensity Locations in Patients with Acute Ischemic Stroke. PLOS ONE, 10, e0144431. https://doi.org/10.1371/journal.pone.0144431
|
[60]
|
Altendahl, M., et al. (2020) An IL-18-Centered Inflammatory Network as a Biomarker for Cerebral White Matter Injury. PLOS ONE, 15, e0227835. https://doi.org/10.1371/journal.pone.0227835
|